“…In recent years, a novel calibration strategy based on isotopologue distribution has been proposed to enable the quantitation of peptide compounds with exceptional accuracy and throughput using LC-MS/MS. , Among these approaches, the in-sample calibration curve (ISCC) stands out as a particularly intriguing strategy, which eliminates the need for laborious preparation of the conventional MSCC by incorporating the calibration curve into each sample to be analyzed. − In LC-MS/MS analysis, matrix effects (MEs) pose an inescapable challenge. , To counter these effects and rectify random errors during sample pretreatment and instrumental analysis, the introduction of a stable isotope internal standard (SIL-IS) to the sample proves effective, which achieves precise quantitative analysis. , To construct the ISCC, an SIL-IS is combined with the multiple isotopologue reaction-monitoring (MIRM) technology. ,,, Here, the abundance of each MIRM is measured by LC-MS/MS, while the theoretical isotopic abundance of each MIRM channel is accurately calculated based on the isotopic distribution of its product ions and neutral loss groups. , With the ability to effectively counter MEs, minimize measurement errors during quantitative analysis, simplify the cumbersome preparation of traditional external calibration curves, and enhance analytical throughput, the ISCC strategy has garnered significant attention and successfully been applied in drug development and environmental analysis. ,,,− However, the ISCC strategy does exhibit notable limitations. The distribution of concentration points within the calibration curve is primarily constrained by the compound’s elemental composition, particularly its correlation with the number of carbon atoms. , In general, compounds with over 20 carbon atoms perform exceptionally well with the ISCC.…”